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Abstract
Background: Angiogenesis is the process by which the highly branched and functional vasculature arises from the major
vessels, providing developing tissues with nutrients, oxygen, and removing metabolic waste. During embryogenesis,
vascular patterning is dependent on a tightly regulated balance between pro- and anti-angiogenic signals, and failure of
angiogenesis leads to embryonic lethality. Using the zebrafish as a model organism, we sought to identify genes that
influence normal vascular patterning.
Methodology and Principal Findings: In a forward genetic screen, we identified mutant LA1908, which manifests massive
apoptosis during early embryogenesis, abnormal expression of several markers of arterial-venous specification, delayed
angiogenic sprouting of the intersegmental vessels (ISV), and malformation of the caudal vein plexus (CVP), indicating a
critical role for LA1908 in cell survival and angiogenesis. Genetic mapping and sequencing identified a G to A transition in
the splice site preceding exon 11 of utp15 in LA1908 mutant embryos. Overexpression of wild type utp15 mRNA suppresses
all observed mutant phenotypes, demonstrating a causative relationship between utp15 and LA1908. Furthermore, we
found that injecting morpholino oligonucleotides inhibiting p53 translation prevents cell death and rescues the vascular
abnormalities, indicating that p53 is downstream of Utp15 deficiency in mediating the LA1908 phenotypes.
Conclusions and Significance: Taken together, our data demonstrate an early embryonic effect of Utp15 deficiency on cell
survival and the normal patterning of the vasculature and highlight an anti-angiogenic role of p53 in developing embryos.
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Introduction
The correct patterning and function of the vascular system is
essential to provide necessary nutrients, oxygen, and growth cues
to perfused tissues, and remove metabolic waste in vertebrate
organisms. During development, failure to form a properly
functioning vasculature is embryonic lethal, complicating attempts
to study this process in vivo. The zebrafish is an exceptional model
organism for the study of early vascular development because it
is amenable to genetic and embryological manipulations. In
addition, zebrafish embryos continue to grow and develop for
several days in the absence of the vasculature or blood circulation,
providing a valuable tool to investigate the progression of vascular
defects [1,2].
In zebrafish, angioblasts, precursors of the endothelial cells
(ECs) that make up the inner lining of the vasculature, arise in
the lateral plate mesoderm during early somitogenesis [3]. During
the process of vasculogenesis, the primitive ECs migrate to the
midline, coalesce into a vascular cord by the 16 somite-stage (ss)
[3], and eventually segregate into the dorsal aorta (DA) and
posterior cardinal vein (PCV) through a cell-sorting process
regulated by EphB4a-ephrinB2a, PI3K, and Notch signaling
[4]. Subsequent expansion of the vascular network from the axial
vessels is governed by angiogenesis. Angiogenesis in the zebra-
fish has been studied almost exclusively in the context of ISV
formation [5]. Primary ISV sprouting initiates bilaterally from
the DA beginning at approximately 20 hours post fertilization
(hpf). The sprout then migrates dorsally to the dorsolateral roof
of the neural tube, where the leading cell branches anteriorly
and posteriorly to form the dorsal longitudinal anastomotic
vessel (DLAV). ISV angiogenesis is primarily regulated by
VEGF, as knockdown of VEGF by antisense morpholinos or
mutation in the VEGF receptor 2 functional ortholog, kdrl,
disrupt normal ISV formation [6–7,8]. Additional signaling
events are required to properly pattern the embryonic vasculature.
For example, induction of Dll4 by VEGF in the leading tip
cell of ISVs activates Notch signaling and inhibits sprouting in
neighboring cells, allowing for proper migration of the nascent
vessel [9,10]. ISV migration is further restricted to somite
boundaries by repulsive interactions between plexinD1 within
the ECs and type 3 semaphorins expressed in the developing
somites [11].
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the caudal vein plexus (CVP) provides a venous-specific angio-
genesis model in zebrafish [12]. The CVP forms via a very active
period of angiogenic sprouting, beginning at 25 hpf when venous
ECs of the PCV sprout and migrate ventrally, then fuse with
neighboring tip cells. This process reiterates during a five-hour
window, forming a primordial plexus by 30 hpf. By two days of
development, the primitive CVP has matured into a complex,
well-perfused, venous vascular network. Although the pro-
angiogenic signals governing sprouting and patterning of the
plexus are still being investigated, roles for Bmp signaling, protein
geranylgeranylation, and Rho signaling in promoting the migra-
tion of venous ECs have been established in this system [12,13].
The tumor suppressor gene, p53, plays a central role in con-
trolling cell cycle and genome stability [14]. Activation of p53
often results in programmed cell death in response to acute cell
stress [14,15]. Genetic studies in the zebrafish and mouse models
provide strong correlation between inactivation of essential genes,
p53 activity, and lethal phenotype [16–17,18,19,20,21]. In
addition to its role in apoptosis, p53 has been directly linked to
regulation of angiogenesis by inducing thrombospondin-1 (Thbs1)
[22,23]. Thbs1 exhibits anti-angiogenic functions through various
mechanisms [24,25]. It has been demonstrated that Thbs1 inhibits
EC migration by activating cell-surface proteins such as CD36 and
b1 integrins through direct binding [25–26,27]. In addition, Thbs1
could prevent the matrix remodeling necessary for EC migration
by inhibiting the matrix metalloprotease (MMP) 3-mediated
cleavage of pro-MMP9 to its active form [24]. Furthermore,
Thbs1 competes with angiogenic growth factors by binding to
extracellular proteoglycans, thereby reducing their bio-availability
[26]. While a strong induction of Thbs1 expression by p53 has
been noted in vitro [22,23], the possible impact of p53 upregulation
on developmental angiogenesis remains to be investigated.
In this report, we describe the isolation of zebrafish mutant
LA1908 from an ENU mutagenesis screen based on the presence
of a severely deformed CVP, delayed ISV formation, and
significant cell death in the central nervous system. We also noted
that several markers of arterial or venous endothelium are mis-
expressed and the expression of thbs1 was significantly upregulated
in LA1908 mutants. Positional cloning identified a point mutation
in the utp15 locus leading to the production of three splice variants
in LA1908. Utp15 is a U3 snoRNA-associated protein of the Small
Subunit Processome (SSU) [28], essential for 18S rRNA
biogenesis. In yeast, loss of any one of the U3 proteins resulted
in 18S rRNA biogenesis defects and disrupts formation of the 40S
small ribosomal subunit [28], but their roles in vertebrate
morphogenesis have not been fully investigated. Injection of wild
type utp15 mRNA was sufficient to rescue all observed defects in
LA1908 mutants, demonstrating a causative relationship between
utp15 deficiency and the vascular and cell survival defects observed
in LA1908. More interestingly, blocking p53 activity in LA1908
completely suppressed apoptosis and rescued the ISV and CVP
defects, indicating that p53 functions downstream of the loss of
Utp15 in these embryos. Finally, the abnormally enhanced thbs1
expression was suppressed by the knockdown of p53 in a dose-
dependent manner. Taken together, our data provide the first
genetic evidence for a p53-mediated anti-angiogenic effect of utp15
deficiency during development.
Results
LA1908 exhibits defects in developmental angiogenesis
In an effort to identify genes important for cardiovascular
development, we performed an ENU mutagenesis screen in
Tg(kdrl:GFP) zebrafish. LA1908 was identified from this screen on
the basis of severe vascular abnormalities at 48 hours post
fertilization (hpf). We utilized confocal microscopy to analyze
vascular development and found that angiogenesis in both the
trunk and the tail regions is abnormal.
In wildtype (WT) embryos, the primary ISV sprouts emerge
from the DA during the segmentation stage and migrate to
approximately the level of the dorsolateral roof of the neural tube
and branch to form the DLAV by 30 hpf (Figure 1C) [5]. We
noted a reduced number of primary ISVs in LA1908 at 25 hpf
(Figure 1A, B and S1F). Mutant ISVs are significantly shorter and
fail to reach the dorsal branching point, preventing formation of
the DLAV in LA1908 at 30 hpf (Figure 1D). Interestingly, the ISV
defects recover by 48 hpf. At this time, LA1908 embryos have a
similar number of ISVs as their WT siblings (data not shown).
These ISVs are patent, regularly spaced, have branched to form
the DLAV (Figure 1E, F), and emerge from both the DA and PCV
(Figure S2), suggesting a delay in ISV angiogenesis. To investigate
if the delay in ISV angiogenesis was a consequence of general
developmental delay in LA1908, we examined somite number and
other morphological parameters commonly used to stage zebrafish
embryos [29] and found no differences between LA1908 and their
WT siblings (Figure S1E). These findings indicate that the vascular
defects observed in LA1908 are likely the result of a specific delay
in vessel formation and demonstrate an effect of LA1908 on the
proper timing of angiogenesis in zebrafish.
In addition, formation of the CVP is markedly defective in
LA1908 embryos. We have previously shown that venous ECs of
the PCV undergo an active angiogenic phase beginning at
approximately 25 hpf (Figure 1A and Movie S1) and develop a
primitive plexus by 30 hpf (Figure 1C) [12]. Time-lapse confocal
images indicate that, while tip cells are able to emerge from the
venous endothelium in LA1908 (Figure 1D), these cells quickly
retract and never develop into mature, migrating ECs (Movie S2).
In contrast to the ISVs, the CVP shows no capacity to recover in
LA1908 at later developmental stages, resulting in failure to form a
complex plexus in the ventral tail region (Figure 1F).
Abnormal vascular gene expression in LA1908
We further characterized the nature of the vascular abnormal-
ities by examining the expression of markers of arterial and venous
identity. The expression of the arterial marker, grl, was
significantly reduced or absent in mutant embryos (Figure 2A,
B). Conversely, the expression of flt4, a marker of venous
differentiation, persists in the DA and the ISVs (Figure 2C–D’).
These data suggest that LA1908 perturbs the normal pattern of
arterial-venous gene expression and may disrupt the expression of
angiogenic regulatory genes. However, pro-angiogenic factors
such as VEGF and BMPs are expressed normally in mutant
embryos (Figure S3), and the expression of neural (krox20) and
hematopoetic (cmyb) differentiation markers is indistinguishable
between WT and mutant embryos (Figure S1 A–D), suggesting
that LA1908 does not disrupt global gene expression, but rather
regulates specific subsets of vascular genes.
LA1908 manifests extensive apoptosis during
somitogenesis
In addition to the vascular defects described above, we observed
a significant level of cell death in the CNS during segmentation
stages in LA1908 mutant embryos, leading to the formation of
smaller heads and eyes (Figure 3A, B). To determine if the cell
death was apoptotic in nature, we performed a whole-mount,
TUNEL-based, fluorescent apoptosis assay and quantified the
results via z-stack confocal microscopy. The number of apoptotic
utp15/p53 Dependent Regulation of Angiogenesis
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to WT siblings, and apoptotic bodies were largely concentrated in
neural tissues of the head and neural tube (Figure 3C–E and data
not shown). Although some apoptotic ECs were observed in the
trunk and ventral tail region of LA1908 mutant embryos, the
number of apoptotic ECs was not significantly different than that
observed in WT siblings. The apoptotic phenotype dissipated by
48 hpf and no significant differences in numbers of apoptotic cells
were observed in 2-day-old WT and mutant embryos (Figure 3E).
This suggests LA1908 plays an important role in promoting cell
survival during early embryogenesis.
LA1908 encodes a G to A transition in the splice acceptor
site preceding exon11 of utp15
We performed positional cloning to identify the molecular lesion
of LA1908. Whole-genome scanning identified genetic linkage
between LA1908 and Z9941 placing the locus on chromosome 18.
Subsequent genotyping of individual mutant embryos revealed
Z9941 was 29.4 cM from the locus. Fine mapping using additional
microsatellite markers further narrowed the interval to 0.7 cM
upstream (7 recombinant chromosomes in 964 meioses) and
0.1 cM downstream (2 recombinant chromosomes in 1122
meioses) (Figure 4A) which encompasses four genes (calub, utp15,
zgc:110373, cd9). Sequencing of the coding regions of these genes
did not identify non-synonymous point mutations. However,
sequence analysis of introns revealed a G to A transition in the
splice acceptor site of intron 10 preceding exon 11 of utp15
(Figure 4B), resulting in the use of alternative AG sites preceding
exon 12, within exon 11, and in intron 10, generating three cryptic
splice variants named utp15 small, utp15 medium, and utp15 large
(Figure 4B). Both utp15 small and utp15 medium cause frame-shifts
and produce truncated Utp15 proteins, while utp15 large causes a
12 amino acid in-frame insertion in the UTP15 C-terminal
superfamily domain (Figure 4C).
We injected wild type utp15 mRNA (WT Utp15) into LA1908
mutant embryos at the 1-cell stage and found that 90% of
WT Utp15-injected mutant embryos developed normally and
were indistinguishable from their WT siblings (Figure 4C,
n=221), demonstrating a causative relationship between the
utp15 mutation and the LA1908 phenotype. Neither Utp15
Figure 1. Confocal microscopic analysis of angiogenesis in LA1908 embryos. A–F, Confocal z-stack projection images were captured of the
trunk and tail vasculature of wild type (A, C, E) and LA1908 mutant (B, D, F) embryos at 25 (A, B), 30 (C, D), or 48 hpf (E, F). CVP endothelial tip cells are
indicated by arrowheads; extent of ISV maturation is indicated by arrows in A–D. Delay of primary ISV sprouting is most prominent at 30 hpf (C and D,
arrows), when WT ISVs have reached their dorsal terminus and branched to form the DLAV (C), while mutant ISVs remain stunted (D). By 48 hpf, ISV
number is equivalent between WT and mutant embryos and DLAV has formed in both groups (E, F, arrows). Defects in CVP angiogenesis result in a
thinner and shorter plexus that lacks the complexity of WT embryos (F versus E). Insets in E and F, enlarged regions indicated by yellow rectangles,
showing ISV lumens. Scale bars are 100 mm.
doi:10.1371/journal.pone.0025013.g001
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phenotype (Figure 4C, n=102 and 136, respectively), indicating
that the truncated proteins encoded by these splice variants are
non-functional. Utp15 large, on the other hand, displayed a slight
ability to rescue the mutant phenotype (15%, n=109) (Figure 4C),
suggesting that the 12aa insertion does not completely abolish the
function of Utp15 and that LA1908 might be a hypomorphic
allele.
utp15 is expressed ubiquitously in early embryos, with
later expression enriched in neural tissues and the
vasculature
We next utilized whole mount in situ hybridization to examine
the expression of utp15 mRNA in WT and mutant embryos.
We discovered that utp15 is ubiquitously expressed in WT embryos
up to the segmentation stage (Figure 5A) and becomes restricted
to the axial vasculature of the trunk and tail as well as to
neural tissues of the CNS in 1-day-old embryos (Figure 5B-B’’).
The enrichment of utp15 expression in the vasculature after 1 day
of development correlates with the vascular patterning and
endothelial cell gene expression defects observed in utp15
LA1908.
Furthermore, whole mount in situ hybridization and quantitative
RT-PCR analyses in stage-matched mutant siblings showed that
total utp15 mRNA levels are drastically reduced in mutant
embryos, indicating that the mutant splice variants are unstable
(Figure 5C, D).
Phenotype in LA1908 is dependent on activation of p53
The activation of p53 plays a key role in cell survival, and
utp15
LA1908 mutant embryos manifest massive programmed cell
death, raising a possibility that p53 may mediate the effect of loss
of Utp15 during early embryogenesis. Consistent with this
hypothesis, expression of p53 was strongly induced in all tissues
of mutant embryos (Figure S4). We further tested whether the
phenotypes of utp15
LA1908 mutant embryos is indeed dependent on
p53 and found that blocking p53 activity using antisense
morpholino oligonucleotides restored gross wild type appearance
in utp15
LA1908 embryos (Figure 6A, B, n=298). Not only is
apoptosis suppressed in early embryogenesis, but the formation of
the ISVs and the CVP (Figure 6A’, B) are normalized in embryos
deficient in both Utp15 and p53. Similarly, the expression patterns
of arterial and venous markers, such as tbx20 (Figure 6C–E), grl,
flt4, ephB4a, aplnra, and dab2 (data not shown) in p53 morpholino-
injected utp15
LA1908 mutant embryos resemble those in WT
embryos. Furthermore, we noted a significant upregulation of
Figure 2. Aberrant expression of arterial and venous endothe-
lial cell markers in LA1908 mutant embryos. A–B, Expression of grl,
an arterial EC marker, was dramatically reduced in LA1908 mutant
embryos (B versus A) at 21 hpf. C–D, Expression of the venous marker,
flt4, was increased and localized ectopically in LA1908 mutant embryos
at 27 hpf (D versus C). Vertical black bars, approximate location of
vibratome cross-sections shown in C’–D’. C’–D’, Vibratome cross-section
of embryos shown in C, D, revealing flt4 expression was appropriately
restricted to the CV in 27 hpf wildtype embryos (C’), but is ectopically
expressed in the DA and ISVs in LA1908 mutant embryos (D’). Embryos
shown are representative from triplicate experiments performed on a
minimum of 5 embryos per condition.
doi:10.1371/journal.pone.0025013.g002
Figure 3. Apoptosis is pervasive in neural tissues of LA1908
mutant embryos. A–B, Brightfield phase-contrast imaging of mutant
embryos revealed craniofacial disorganization and extensive cell death
(hazy dark brown appearance in midbrain in B versus A). C–D’,
Apoptosis is significantly induced in LA1908 mutant embryos (D, D’)
relative to stage-matched WT siblings (C, C’). Green fluorescence marks
the endothelial cells. Red fluorescence indicates apoptotic cells
detected by TUNEL assay. ACeV, Anterior cerebral vein. ey, eye
primordium. hrt, embryonic heart. MCeV, Middle cerebral vein. PMBC,
Primordial midbrain channel. E, Quantitative and statistical analyses of
apoptotic bodies at several stages of development in WT versus mutant
embryos. *=p-value,0.05, **=p-value,0.005, ***=p-value,0.00005
by two-tailed t-test, n=3 embryos for each condition, data are
average6SEM.
doi:10.1371/journal.pone.0025013.g003
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(Figure 6F, G). Blocking p53 activity down-regulates thbs1
expression in a dosage-dependent manner (Figure 6G–I). Taken
together, these findings indicate a p53-dependent effect of Utp15
deficiency during zebrafish development.
Discussion
Utp15 is a U3 snoRNA-associated protein involved in the
cleavage of pre-ribosomal RNA. Depletion of Utp proteins affects
the production of 18S rRNA in yeast [28]. The requirements for
Utp proteins during development is elusive, but the findings that
zebrafish insertional mutations perturbing utp15 and utp11-like
genes lead to embryonic lethality [17] indicate an essential role for
Utp proteins in vertebrate embryogenesis. Here we report the
isolation of utp15
LA1908, a zebrafish mutant carrying a point
mutation affecting the splicing of utp15. Similar to the insertional
mutant, utp15
hi1370Tg, utp15
LA1908 is embryonic lethal. In addition,
we find that embryos deficient in utp15 manifest massive apoptosis
during the first day of development. Starting from the second day
of development, the number of apoptotic cells decreases in
utp15
LA1908, and no significant differences in the number of
apoptotic bodies are observed between mutant embryos and their
WT siblings by 48 hpf, indicating a requirement for Utp15 in cell
survival during early embryogenesis. We further found that
blocking p53 activity is sufficient to suppress apoptosis in
utp15
LA1908. This is very similar to results obtained in the zebrafish
bap28 mutant. BAP28 shares low similarity to yeast utp10, and its
activity is required for the biogenesis of rRNA in zebrafish [30].
Loss-of-function of bap28 in zebrafish induces p53-dependent
apoptosis in the CNS [30]. Phenotypic similarities between utp15
and bap28 suggest a p53-dependent cell survival mechanism in
response to ribosomal biogenesis stress. This idea is strongly
supported by previous studies in cultured mammalian cells, which
demonstrated that p53 activity is sensitive to errors in rRNA
biogenesis [19].
Figure 4. The LA1908 locus encodes zebrafish utp15. A, Positional cloning showed tight linkage between LA1908 and utp15. B, Sequence
analysis of the utp15 gene revealed an intronic G to A point mutation, abolishing the splice acceptor site preceding exon11 and resulting in three
utp15 cryptic splicing variants; a 134 bp deletion (utp15 small), a 26 bp deletion (utp15 medium), and a 36 bp insertion (utp15 large). Inset in (B) shows
the relative cDNA sizes of S (utp15 small), W (wild type utp15), M (utp15 medium), and L (utp15 large) variants. C, The protein structure and
translational consequences of utp15 splice variants. Utp15 small and medium proteins contain premature stop codons resulting in truncated proteins.
Injecting in vitro synthesized mRNA generated from these constructs was unable to rescue LA1908 mutant phenotype. Utp15 large contains a 12
amino acid insertion and displays some ability to rescue phenotype. Red bar, WD40 protein-protein interaction domain. Blue bar, utp15 C-terminal
superfamily domain of unknown function. Green bar, altered peptide sequence resulting from cryptic splicing. *=p-value ,0.001 by Chi-Squared
analysis of Mendelian ratios of a minimum of 100 embryos per condition. Rescue efficiency is calculated as # embryos exhibiting LA1908 mutant
phenotype/# total embryos with LA1908 mutant genotype, n=10 (WT), 28 (small), 11 (medium), and 13 (large) mRNA injected mutant embryos.
doi:10.1371/journal.pone.0025013.g004
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investigated. The defects we observe in utp15
LA1908, including the
altered timing of ISV formation and perturbed morphogenesis of
the CVP as well as the mis-expression of arterial and venous
markers, demonstrate a previously unappreciated role for Utp
proteins in angiogenesis. Mechanisms by which Utp15 deficiency
perturbs angiogenesis are unclear. It is possible that massive
apoptosis during segmentation stages induces systemic inflamma-
tory responses in the developing zebrafish and thereby affects
normal angiogenesis in a non-cell autonomous manner. Alterna-
tively, loss of function of Utp15 may directly influence the
formation of embryonic vasculature. The expression of utp15
becomes enriched in the vasculature after one day of development,
which coincides with the appearance of vascular defects in
utp15
LA1908 embryos and suggests that utp15 may also have cell
autonomous roles in later vascular developmental processes.
Regardless of whether Utp15 influences embryonic anigogenesis
through a cell-autonomous or a non-cell autonomous mechanism,
the finding that blocking p53 activity in utp15
LA1908 mutant
embryos could suppress the vascular phenotypes suggests that the
effect of Utp15 deficiency on angiogenesis is mediated by p53.
Inhibitory effects of p53 on angiogenesis via repressing the
production of VEGF or promoting the production of anti-
angiogenic factors such as Thbs-1 have previously been noted
[22,23,31,32]. Interestingly, the expression of thbs1 is upregulated
in tissues adjacent to the ISVs and CVP in utp15
LA1908 embryos.
Knocking down p53 activity eliminated the upregulation of thbs1
and rescued the angiogenesis defects in utp15
LA1908, suggesting that
disruption of ribosomal biogenesis induces a p53-Thbs1-mediated
anti-angiogenic pathway.
In this study, we noted that the delay of ISV formation
recovered by two days of development, but the defect in CVP
formation was permanent in utp15
LA1908 embryos. Mechanisms
underlying the disparate impact of Utp15 deficiency on ISV and
CVP formation require further investigation. One attractive possi-
bility is the potential of distinct pro-angiogenic signals mediating
ISV versus CVP formation and that signals governing ISV
sprouting are stable during early development whereas the growth
cues for the CVP are transient. The significance of signaling from
the somite-produced VEGF ligand to the VEGFR2/kdrl receptors
on the endothelial cells in ISV formation has been firmly
established [6,8,9,33], whereas emerging evidence suggests that
BMPs in the ventral tail mesenchyme promote caudal vein plexus
formation [13]. Interestingly, we found that the production of
VEGF in the ventral somites persists through embryonic day 2
(Figure S2), while expression of the BMPs 2b and 4 in the ventral
tail is high at the onset of CVP angiogenesis (Figure S2) but fades
away soon afterwards (Figure S2). The dynamic expression
patterns of VEGF and BMPs are consistent with our postulation
that a stable pro-angiogenic signal such as VEGF allows the
recovery of ISV formation whereas transient signals such as BMPs
prevent the CVP formation at later developmental stages in
utp15
LA1908 embryos. Further analysis of the relationship between
VEGF and BMP signaling and ISV and CVP angiogenesis will
help clarify the dynamic regulatory mechanisms of angiogenesis in
different vascular beds in the zebrafish embryo.
Materials and Methods
Zebrafish Husbandry
LA1908 was isolated from F2 intercrosses of Tg(kdrl:GFP)
LA116
zebrafish mutagenized by treatment with ENU according to
standard protocols [34,35]. Fish and embryos were maintained as
described previously [29].
Figure 5. Analysis of endogenous utp15 expression by whole-mount in situ hybridization. A, utp15 is expressed ubiquitously in
developing embryos at early stages. B, Expression was restricted to neural and vascular tissues after one day of development. B’, 2x magnification of
the rectangular region indicated in (B), showing expression in the dorsal aorta and cardinal vein. Red bar, approximate location of the vibratome
cross-section shown in (B’’). C–D, utp15 was dramatically reduced in mutant embryos, as shown by in situ hybridization (C) and qRT-PCR (D) analyses.
A–C, Embryos shown are representative of triplicate experiments performed on a minimum of 5 embryos per condition. D, Data shown are the
average fold changes in expression6SEM from two replicate qRT-PCR assays using pooled RNA from 20 embryos per condition.
doi:10.1371/journal.pone.0025013.g005
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Confocal Z-stack images of utp15
LA1908 embryos and their wild
type siblings were captured using a Zeiss LSM510 epifluorescent
laser scanning microscope equipped with an Achroplan 20x/0.5W
water immersion objective. Z-stack projections were created using
Zeiss LSM Image Browser Software (ver. 4.2.0.121, Carl Zeiss,
Inc.). Live embryos were anesthetized in 0.01% tricaine and both
live and fixed embryos were embedded laterally in 1% agarose.
Whole-Mount In Situ Hybridization
Embryos for in situ hybridization were raised in embryo
medium supplemented with 0.2 mM 1-phenyl-2-thiourea to
maintain optical transparency [29]. Whole-mount in situ hybrid-
ization was performed as described previously [36]. Briefly,
embryos were fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS), followed by dehydration in methanol.
Embryos were digested with proteinase K and then pre-incubated
in hybridization buffer (65% formamide, 5X SSC, 5mg/ml torula
yeast RNA, 50 mg/ml heparin, 0.1% Tween-20), then hybridized
with digoxigenin-labeled antisense probes overnight at 67uC. The
antisense RNA probes used in this study include grl, flt4, ephB4a,
ephrinB2a, kdrl, krox20, cmyb, utp15, p53, tbx20, dab2, and aplnra.
Embryos were washed in solutions of decreasing osmolarity and
then blocked in 5% goat serum, 2mg/ml BSA in PBT (PBS+0.1%
Tween-20). Labeled probes were detected using an alkaline
phosphatase-conjugated anti-digoxigenin antibody followed by
reaction in the presence of nitro-blue tetrazolium and 5-Bromo-4-
chloro-3-indolyl phosphate. Stained embryos were mounted in
3.25% methylcellulose and imaged on a Zeiss Stemi SV11 Apo
stereomicroscope using AxioVision software (ver. 4.8.1.0, Carl
Zeiss, Inc.) under direct lighting.
Vibrating microtome sectioning of embryos stained by
whole-mount in situ hybridization
Embryos stained by whole mount in situ hybridization were
mounted tail-down in 4% (W/V) low-melt agarose (Fisher)
dissolved in E3. An agar plug containing the embedded embryos
was cut and affixed to the tray of a 1000 Plus Sectioning System
(The Vibratome Company). 100 mm sections were cut into ice-
cold PBS at speed=5 and amplitude=4. Sections were mounted
onto standard laboratory slides and imaged on a Zeiss Axioplan2
compound microscope using automatic ExtendedFocus
TM and a
20x/0.50 Ph.2 objective.
Positional Cloning
Whole-genome scanning for genetic linkage was performed by
PCR amplification of microsatellite repeats from pooled WT
versus mutant genomic DNA (gDNA) samples using published
Figure 6. Loss of function of utp15 induces p53 activity. A, Brightfield Phase contrast images of 30 hpf embryos. LA1908 mutant embryos
manifest defects in the brain and the vasculature as well as a significantly shorter body when compared to their wild type siblings. Injection of 2 ng
p53MO is sufficient to prevent CNS necrosis (A), restore normal CVP morphology (A’), and normalize the gross morphology of the mutant embryos. A’,
Magnified image of boxed regions of Tg[kdrl:GFP] embryos in (A). Note normal ISV patterning and presence of EC sprouting within the CVP (white
arrows), resulting in a prototypical plexus. B, Chi-squared analysis of WT:Mutant ratios from 3 independently replicated experiments. n=220
uninjected control embryos, 298 2 ng p53MO-injected embryos, *=p-value,0.001. Data are average +/- SEM. C–E, Analysis of tbx20 expression, a
marker of arterial endothelial cells, demonstrated p53MO also restores normal expression levels and patterning (E) which were lost in mutants (D)
relative to WT (C) embryos. Embryos are representative of experiments performed in triplicate on a minimum of 5 embryos per condition. F–H, thbs1
is expressed in a p53-dependent manner. Under normal conditions (F), expression is observed in the floor plate, dorsal neural tube, and in the ventral
somites/axial vasculature. In mutant embryos, thbs1 expression is substantially upregulated (G). Knockdown of p53 reduced thbs1 expression in a
dose-dependent manner. Roughly half (18/41) of the embryos injected with 2 ng p53MO have thbs1 levels as shown in (H), with the remainder (23/
41) displaying WT (F) levels. When the dose is increased to 4 ng (I), 82% of embryos (31/38) had WT (F) levels of thbs1 mRNA, while only 18% (7/38)
appeared as in (H).
doi:10.1371/journal.pone.0025013.g006
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fixed embryos at 55u overnight in 50 mL lysis buffer composed of
proteinaseK at 100 mg/mL, 10 mM Tris pH 8.0, 2 mM EDTA,
and 0.2% (V/V) TritonX-100. Once linkage to a specific chromo-
some had been identified, additional primers were designed
flanking tandem repeats and tested for polymorphisms in pooled
gDNA samples. Primer sequences of the custom markers 745.25-7
and 594.7-3 are:
745.25-7 F 59-GCAATGCGTAAGGAATGCTGGGAA-39
R5 9-GTGTGAGTGTTCTGCTCACGTGTTTG-39
594.7-3 F 59-AGTCTGCGTTCATCTTCCACGAGT-39
R5 9-GCTGGATCTGATGTGGTGTGTTCTGA-39
Identification of recombinant chromosomes in individual
mutant embryos revealed distance and orientation to the mutant
loci.
Molecular Cloning
RNA was extracted from pooled samples of WT or mutant
embryos using Trizol reagent according to the manufacturer’s
protocol (Invitrogen). RNA was resuspended in 1 mLH 20/
embryo. cDNA was synthesized from 1 mg RNA using the iScript
cDNA synthesis kit (Bio-Rad Laboratories). High-fidelity amplifi-
cation of target genes was performed using KOD enzyme
according to manufacturer’s protocol (TaKaRa). utp15 (all
isoforms) was cloned into the pCS2 3x FLAG Tag vector with
the tag at the N-terminus (pCS2 N FT). After a brief incubation
with Taq polymerase at 72u, a fragment of thbs1 was cloned into
pCRII TOPO according to the manufacturer’s instructions.
Sequence analysis of all vectors confirmed presence and
orientation of insert.
In vitro mRNA synthesis and microinjections
mRNA for microinjections was synthesized from 1 mg pCS2 N
FT utp15 plasmids linearized 39 to the polyA site using the
mMessage mMachine Sp6 Kit (Ambion) according to the
manufacturer’s instructions. RNA concentration was determined
by A260:A280 ratio on a SmartSpec3000 Spectrophotometer (Bio-
Rad Labortatories). 100 pg of RNA was injected in 1 nL into a
minimum of 100 1-cell stage utp15
LA1908 embryos per utp15
isoform.
qRT-PCR
RNA was extracted from WT and mutant embryos and cDNA
synthesized as described above. Relative gene expression was
determined by SYBR green based quantitative RT-PCR per-
formed on a BioRad iCycler iQ and analyzed using the BioRad
Gene Expression Analysis Macro for Microsoft Excel. Primers
were designed using the IDT SciTools online design suite to span
exon-exon boundaries where possible and analyzed for minimal
secondary structure using the Mfold web server [38]. Primer
sequences are as follows:
Danio rerio gapdh F5 9- TGTGATGGGAGTCAACCAGGA-
CAA-39
R5 9- TTAGCCAGAGGAGCCAAGCAG-
TTA-39
Danio rerio utp15 F5 9- CCTGTGCATGTCTGAGTTCAA-
GCAAC-39
R5 9- GCCAGACTGAGAATAGATGAC-
GCACA-39
Whole-Mount Apoptosis Assay
Apoptosis was visualized in situ using the ApopTag Red in situ
cell death detection kit (Millipore), which utilizes Terminal
deoxynucleotidyl transferase (TdT) dUTP nick end labeling
(TUNEL) chemistry to deposit digoxigenin-labeled nucleotides
onto the free 39-OH termini of cleaved DNA. Embryos were fixed,
dehydrated, and digested with Proteinase K as described above.
Embryos were then washed in Equilibration Buffer, followed by
reaction with TdT. Deposition was stopped in Stop/Wash buffer.
Embryos were then blocked in 5% goat serum, 2 mg/mL BSA in
PBT. Embryos were stained with the supplied Rhodamine-
conjugated anti-digoxigenin antibody diluted in Millipore Block-
ing Solution according to manufacturer’s protocol and digox-
igenin-positive nuclei were detected by confocal microscopy and
counted in Adobe Photoshop CS4 using the Count Tool.
Supporting Information
Figure S1 Gene expression in LA1908 is not globally
disrupted. A–D, Markers of neural (krox20, A, B) and
hematopoietic (cmyb, C, D) differentiation were indistinguishable
between wild type and mutant embryos. n=20 embryos for each
condition. E–F, Development was not generally delayed, as somite
number was not significantly different between LA1908 mutant
and wild type siblings (E). Rather, delay was specific to vascular
tissues, exemplified by decreased ISV number in mutant versus
wild type embryos at 21 hpf (F). Ten embryos were analyzed per
condition. NS=not significantly different, *=p,0.00005.
(TIF)
Figure S2 ISVs of both arterial and venous origin are
present in LA1908 mutant embryos. A–B, Confocal z-stack
projection images of Tg[kdrl:GFP]
LA1908 wildtype (A) or mutant
(B) embryos. A’–B’’, Single 2.75 mm z-slices of the region outlined
in yellow in (A, B), revealing the axial vessel origin of ISVs in day 2
embryos. A’–B’, ISVs originating from the DA are indicated by a
red ‘‘A’’. A’’–B’’, ISVs originating from the PCV are indicated by
a blue ‘‘V’’. Scale bars are 100 mm.
(TIF)
Figure S3 Expression of growth factors is unchanged in
LA1908 mutant embryos. Expression of bmp2b (A–D), bmp4
(E–H), and vegfaa (I–L) is indistinguishable between stage-matched
wild type (A, C, E, G, I, K) and mutant (B, D, F, H, J, L) embryos.
Furthermore, expression of vegfaa, the pro-angiogenic signal for
ISV angiogenesis, persists in the ventral somites through the time-
point after which apoptosis has resolved in LA1908 mutant
embryos (K, L), whereas putative CVP pro-angiogenic signals in
the ventral tail, bmp2b and bmp4, are absent from the ventral tail
after one day of development (C, D, G, H), possibly explaining the
differential ability of CVP versus ISV angiogenesis to recover after
initial delay.
(TIF)
Figure S4 Induction of p53 mRNA expression in LA1908
mutant embryos. A–B, Expression of p53 mRNA is strongly
induced by loss of utp15. Upregulation is observed in all tissues in
mutant (B) relative to wildtype (A) embryos. C–D, Vibratome
cross-section of embryos shown in Figure 6 F–G, revealing
induction of thbs1, particularly in the dorsolateral roof and floor
plate of the neural tube.
(TIF)
Movie S1 CVP sprouting is active between 25 and 28 hpf
in wildtype embryos. Time-lapse confocal images of wild type
embryos in Tg[kdrl:GFP] genetic background from 25–28 hpf.
Venous endothelial sprouts are clearly evident during CVP
development in WT embryos, maturing into ventrally migrating
tip cells to form the primitive plexus.
(WMV)
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PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e25013Movie S2 CVP sprouting is defective in LA1908 mutant
embryos. Time-lapse confocal images of LA1908 mutant
embryos in Tg[kdrl:GFP] genetic background from 25–28 hpf.
Transient venous endothelial sprouts were formed, but quickly
retracted and rarely matured into ventrally migrating tip cells
(indicated by arrows).
(WMV)
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